Log in to save to my catalogue

Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification o...

Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2604011466

Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas

About this item

Full title

Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas

Publisher

Singapore: Springer Singapore

Journal title

Brain tumor pathology, 2022-01, Vol.39 (1), p.14-24

Language

English

Formats

Publication information

Publisher

Singapore: Springer Singapore

More information

Scope and Contents

Contents

Since the World Health Organization 2016 classification (2016 WHO), genetic status has been incorporated into the diagnosis of Grade 2/3 gliomas (lower-grade gliomas). Therefore, immunohistochemistry (IHC) of IDH1-R132H, ATRX, and p53 have been used in place of genetic status. We report the associations between histological findings, IHC, and genet...

Alternative Titles

Full title

Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2604011466

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2604011466

Other Identifiers

ISSN

1433-7398

E-ISSN

1861-387X

DOI

10.1007/s10014-021-00418-x

How to access this item